Cronos Group Inc. - ROE
CRON
Price:
$2.71
Market Cap:
$1.00B
Cronos Group Inc. is a company primarily focused on cannabinoids. In the United States, it develops, promotes, and supplies hemp-derived wellness and beauty products under the Lord Jones and Happy Dance brands, reaching consumers through online sales, traditional retail outlets, and partnerships within the hospitality sector. Beyond hemp, the company also engages in the cultivation, production, and commercialization of cannabis and its related extracts for both therapeutic and recreational consumption. Its cannabis offerings encompass dried flower, pre-rolled joints, edibles, concentrates, and various extracts, which are distributed via wholesale channels and directly to clients. The wellnes...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2018-02-27
Stock Exchange
NASDAQ
Ticker
CRON
PE Ratio
[-135.50]
ROE
[-0.19%]
Current Ratio
[21.87]
Dividend Yield
[0%]
Enterprise Value
[183.85M]
Dividend History
The ROE as of June 2026 (TTM) for Cronos Group Inc. (CRON) is -0.19%
According to Cronos Group Inc.’s latest financial reports and current stock price. The company's current ROE is -0.19%. This represents a change of 322.40% compared to the average of -0.05% of the last 4 quarters.
Cronos Group Inc. (CRON) Historical ROE (quarterly & annually)
How has CRON ROE performed in the past?
The mean historical ROE of Cronos Group Inc. over the last ten years is -0.40%. The current -0.19% ROE has changed -52.21% with respect to the historical average. Over the past ten years (40 quarters), CRON's ROE was at its highest in in the March 2019 quarter at 43.16%. The ROE was at its lowest in in the June 2021 quarter at -10.97%.
Average
-0.40%
Median
-3.89%
Minimum
-29.37%
Maximum
65.01%
Cronos Group Inc. (CRON) ROE by Quarter and Year
Discovering the peaks and valleys of Cronos Group Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 589.59%
Maximum Annual ROE = 65.01%
Minimum Annual Increase = -663.59%
Minimum Annual ROE = -29.37%
| Year | ROE | Change |
|---|---|---|
| 2025 | -0.88% | -122.82% |
| 2024 | 3.86% | -157.48% |
| 2023 | -6.71% | -54.92% |
| 2022 | -14.88% | -49.33% |
| 2021 | -29.37% | 589.59% |
| 2020 | -4.26% | -106.55% |
| 2019 | 65.01% | -663.59% |
| 2018 | -11.54% | 581.34% |
| 2017 | -1.69% | -51.81% |
| 2016 | -3.51% | -247.49% |
Cronos Group Inc. (CRON) Average ROE
How has CRON ROE performed in the past?
The current ROE of Cronos Group Inc. (CRON) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.24%
5-year avg
-9.60%
10-year avg
-0.40%
Cronos Group Inc. (CRON) ROE vs. Peers
How is CRON’s ROE compared to its peers?
Cronos Group Inc.’s ROE is less than Pacira BioSciences, Inc. (0.73%), less than Collegium Pharmaceutical, Inc. (26.74%), greater than Embecta Corp. (-17.49%), less than IRadimed Corporation (24.48%), less than Amphastar Pharmaceuticals, Inc. (10.23%), greater than Rapport Therapeutics, Inc. Common Stock (-24.79%), greater than Nurix Therapeutics, Inc. (-64.21%), greater than BridgeBio Oncology Therapeutics Inc. (-61.49%), greater than Xencor, Inc. (-28.77%), less than Phathom Pharmaceuticals, Inc. (39.24%),
| Company | ROE | Market cap |
|---|---|---|
| 0.73% | $878.35M | |
| 26.74% | $1.09B | |
| -17.49% | $184.51M | |
| 24.48% | $1.18B | |
| 10.23% | $829.39M | |
| -24.79% | $1.36B | |
| -64.21% | $1.52B | |
| -61.49% | $605.61M | |
| -28.77% | $937.15M | |
| 39.24% | $867.74M |
Build a custom stock screener for Cronos Group Inc. (CRON) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cronos Group Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Cronos Group Inc. (CRON) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Cronos Group Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Cronos Group Inc.'s ROE?
How is the ROE calculated for Cronos Group Inc. (CRON)?
What is the highest ROE for Cronos Group Inc. (CRON)?
What is the 3-year average ROE for Cronos Group Inc. (CRON)?
What is the 5-year average ROE for Cronos Group Inc. (CRON)?
How does the current ROE for Cronos Group Inc. (CRON) compare to its historical average?